Skip to main content
Research with human participants
Overview of medical research in the Netherlands
Language
English
Dutch
Menu
Close
Home
Research participant
Professionals
Latest
About OMON
Search
CCMO.nl
Search for a trial
Search for medical examination, illness or treatment
Sort by
Relevance
Publication date
Mutation date
1 results
Sort by
Relevance
Publication date
Mutation date
A randomized phase III study to evaluate the efficacy of chemoimmunotherapy with the monoclonal antibody Campath-1H (Alemtuzumab) given in combination with 2-weekly CHOP versus 2-weekly CHOP alone in elderly patients with previously untreated systemic peripheral T-cell lymphomas
Approved WMO
Completed
See C4